Rogue stem cell clinics. (February 2020)

• Record Type: Journal Article
• Authors: Murray, Iain R.; Chahla, Jorge; Frank, Rachel M.; Piuzzi, Nicolas S.; Mandelbaum, Bert R.; Dragoo, Jason L.
• Is Part Of: Bone & joint journal. Volume 102B:Number 2(2020)
• Page Start: 148
• Page End: 154
• Publication Date: 2020-02
• Subjects: Stem Cells -- Biologics -- Regulation -- Direct to consumer marketing; Bones -- Surgery -- Periodicals; Joints -- Surgery -- Periodicals; Orthopedic surgery -- Periodicals; 617.47005
• DOI: 10.1302/0301-620X.102B2.BJJ-2019-1104.R1
• Languages: English
• ISSNs: 2049-4394

Abstract

Abstract : Cell therapies hold significant promise for the treatment of injured or diseased musculoskeletal tissues. However, despite advances in research, there is growing concern about the increasing number of clinical centres around the world that are making unwarranted claims or are performing risky biological procedures. Such providers have been known to recommend, prescribe, or deliver so called 'stem cell' preparations without sufficient data to support their true content and efficacy. In this annotation, we outline the current environment of stem cell-based treatments and the strategies of marketing directly to consumers. We also outline the difficulties in the regulation of these clinics and make recommendations for best practice and the identification and reporting of illegitimate providers. Cite this article: Bone Joint J 2020;102-B(2):148–154